Reply to comment on: Massive transfusion experience, current practice and decision support: A survey of Australian and New Zealand Anaesthetists.

Journal article

Sanderson BJ. et al, (2022), Anaesth Intensive Care, 50, 337 - 338

Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used

Journal article

Kohli R. et al, (2022), Journal of Clinical Apheresis

Insights from developing and evaluating the NHS blood choices transfusion app to support junior and middle‐grade doctor decision making against guidelines

Journal article

Dhesi AS. et al, (2022), Transfusion Medicine

Convalescent plasma donors show enhanced cross-reactive neutralising antibody response to antigenic variants of SARS-CoV-2 following immunisation.

Journal article

Harvala H. et al, (2022), Transfusion

Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.

Journal article

Estcourt L. and Callum J., (2022), N Engl J Med, 386, 1753 - 1754

Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.

Journal article

Ratcliff J. et al, (2022), J Clin Microbiol

Determinants of passive antibody effectiveness in SARS-CoV-2 infection

Stadler E. et al, (2022)

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal article

REMAP-CAP Writing Committee for the REMAP-CAP Investigators None. et al, (2022), JAMA

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676

Passive immune therapies: another tool against COVID-19.

Journal article

Estcourt LJ., (2021), Hematology Am Soc Hematol Educ Program, 2021, 628 - 641

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Journal article

Axfors C. et al, (2021), BMC Infectious Diseases, 21

Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction

Ratcliff J. et al, (2021)

The difference in potential harms between whole blood and component blood transfusion in major bleeding: a rapid systematic review and meta-analysis of RCTs

Journal article

Geneen LJ. et al, (2021), Transfusion Medicine Reviews

Hyperimmune immunoglobulin for people with COVID-19

Journal article

Kimber C. et al, (2021), Cochrane Database of Systematic Reviews, 2021

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal article

Writing Committee for the REMAP-CAP Investigators None. et al, (2021), JAMA

Living systematic reviews in a context of rapidly emerging diseases: challenges and lessons learned

Conference paper

Iannizzi C. et al, (2021), EUROPEAN JOURNAL OF PUBLIC HEALTH, 31, 182 - 182

Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.

Journal article

Ernst M. et al, (2021), Cochrane Database Syst Rev, 9

SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Journal article

Kreuzberger N. et al, (2021), Cochrane Database Syst Rev, 9

Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper

Journal article

Iannizzi C. et al, (2021), Journal of Clinical Epidemiology

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Journal article

ATTACC Investigators None. et al, (2021), N Engl J Med, 385, 790 - 802